Exploration of the role of cisplatin on transformation of larvngeal tumor cells to stem-like cancer cells.
- Author:
Maomao AI
;
Feng YU
;
Xin HUANG
- Publication Type:Journal Article
- MeSH:
Antineoplastic Agents;
pharmacology;
Cell Differentiation;
Cell Line, Tumor;
Cell Separation;
Cisplatin;
pharmacology;
Flow Cytometry;
Humans;
Laryngeal Neoplasms;
pathology;
Neoplastic Stem Cells;
drug effects;
RNA, Messenger;
Signal Transduction;
beta Catenin
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2015;29(4):346-351
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the possibility mechanism of non-side population cells (NSP) of Hep-2 be induced into stem-like cancer cells by chemotherapy drug--cisplatin.
METHOD:Hep-2 cell lines were sorted by fluorescence-actived cell sorting. The acquired NSP cells in trail group were co-cultured with cisplatin for more than 48 hours,while the control group with normal saline(NS). Then identified the percentage of the side population (SP) cells by flow cytometer. The β-catenin, notch-1 mRNA in trial and control group were detected using quantitative realtime PCR, and the β-catenin, notch-1 protein in two groups were compared by Western blot.
RESULT:The percentage of side population cells in two groups were (17.16 ± 0.18)%, (10.05 ± 1.20)%, respectively. There was significant difference between two groups (t = 5.844, P < 0.01). The expression of β-catenin, notch-1 was higher in trail group by qRT-PCR; the protein levels of β- catenin, notch-1 was found to inceased in the trail group by Western blot (t = 5.155, P = 0.031; t = 5.977, P = 0.004). Statistical analysis showed significant difference between two groups (P < 0.05).
CONCLUSION:NSP cells can be differentiated into stem-like cancer cells after being treating with cisplatin. The supposed mechanism is maybe through wnt/β-catenin, notch signaling transduction pathway abnormalities.
